Biofrontera Profit Margin

Biofrontera (BFRI) currently reports a profit margin of -13.78% as of June 2026. That compares with -42.35% in the prior-year period — up 67.4% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Biofrontera's profit margin history and peer comparisons.

Biofrontera's profit margin increased from -42.35% to -13.78% — a 67.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biofrontera's profit margin of -13.78% is lower than the Healthcare sector average of 13.89%. That is roughly 199.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Biofrontera's current -13.78% should be judged against Healthcare norms (sector average: 13.89%) and against BFRI's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -13.78%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Biofrontera, and consider following BFRI for alerts when major investors trade the stock.